[{"data":1,"prerenderedAt":120},["ShallowReactive",2],{"drug-pioglitazone":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":51,"contraindications":97,"warnings":107,"renal":108,"monitoring":109,"interactions":110,"review":111,"examples":114},"pioglitazone",1,{"fa":7,"en":8},"پیوگلیتازون","Pioglitazone","endocrine",{"fa":11,"en":12},"تیازولیدین‌دیون","Thiazolidinedione",[14],{"name":15,"market":16},"Actos","US",[18,19,7],"actos","اکتوس",[21,35,43],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":30,"refs":31},"tab-15","tablet","oral","15 mg tablet",{"amount":27,"unit":28,"perUnit":23,"scored":29},15,"mg",false,[16],[32],{"source":33,"section":34},"fda-pioglitazone","3",{"id":36,"form":23,"route":24,"label":37,"concentration":38,"markets":40,"refs":41},"tab-30","30 mg tablet",{"amount":39,"unit":28,"perUnit":23,"scored":29},30,[16],[42],{"source":33,"section":34},{"id":44,"form":23,"route":24,"label":45,"concentration":46,"markets":48,"refs":49},"tab-45","45 mg tablet",{"amount":47,"unit":28,"perUnit":23,"scored":29},45,[16],[50],{"source":33,"section":34},[52,82],{"id":53,"disease":54,"label":55,"population":58,"type":62,"unit":28,"dose":63,"refs":64,"limits":70,"notes":73},"adult","type-2-diabetes",{"fa":56,"en":57},"دیابت نوع ۲ — شروع ۱۵ یا ۳۰ mg یک بار در روز","Type 2 diabetes — start 15 or 30 mg once daily",{"minAge":59},{"value":60,"unit":61},18,"year","fixed",{"perDose":27,"perDoseMax":39,"dosesPerDay":5},[65,68],{"source":66,"section":67},"fda-pioglitazone-b","2.1",{"source":66,"section":69},"2",{"maxPerDay":47,"refs":71},[72],{"source":66,"section":69},[74],{"text":75,"refs":78},{"fa":76,"en":77},"نارسایی قلبی NYHA I–II: شروع ۱۵ mg. افزایش ۱۵ mg تا حداکثر ۴۵. با جم‌فیبروزیل یا مهارکننده قوی CYP2C8 حداکثر ۱۵ mg.","NYHA I–II heart failure: start 15 mg. Increase by 15 mg up to 45. With gemfibrozil or strong CYP2C8 inhibitors max 15 mg.",[79,80],{"source":66,"section":69},{"source":66,"section":81},"2.3",{"id":83,"disease":54,"label":84,"population":87,"type":89,"unit":28,"dose":90,"refs":94},"peds",{"fa":85,"en":86},"زیر ۱۸ سال","Under 18 years",{"maxAge":88},{"value":60,"unit":61},"notCalculated",{"reason":91},{"fa":92,"en":93},"در کودکان توصیه نمی‌شود.","Not recommended in children.",[95],{"source":66,"section":96},"8.4",[98],{"id":99,"severity":100,"text":101,"refs":104},"hf","block",{"fa":102,"en":103},"هشدار جعبه‌ای: شروع در نارسایی قلبی NYHA III یا IV ممنوع است.","Boxed warning: initiation in NYHA class III or IV heart failure is contraindicated.",[105],{"source":66,"section":106},"Boxed Warning",[],[],[],[],{"status":112,"reviewer":113,"date":113},"unverified",null,[115],{"regimen":53,"formulation":22,"input":116,"expect":119},{"ageYears":117,"weightKg":118},55,80,{"perDose":27,"upperPerDose":39},1792078539584]